Get startedLog in
    Picture of NuVasive logo

    NUVA — NuVasive News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedMid Cap
    All News

    Brief: Nuvasive Receives FDA Clearance For Expanded Indications Of Use For Attrax Putty With Co's Thoracolumbar Interbody Portfolio

    Picture of NuVasive logoNuVasive
    05/01/2022 12:55
    Jan 5 (Reuters) - NuVasive Inc  NUVA.O :
    * NUVASIVE RECEIVES FDA CLEARANCE FOR EXPANDED INDICATIONS
OF USE
FOR ATTRAX PUTTY WITH COMPANY'S THORACOLUMBAR INTERBODY
PORTFOLIO

Source text for Eikon:  ID:nPn6DdNm3a 
Further company coverage:  NUVA.O 

 ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on NuVasive

    See all news